Search Results - "Cano, Maria V."

Refine Results
  1. 1

    Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018 by Su, John R., McNeil, Michael M., Welsh, Kerry J., Marquez, Paige L., Ng, Carmen, Yan, Ming, Cano, Maria V.

    Published in Vaccine (29-01-2021)
    “…Myopericarditis after vaccination has been sporadically reported in the medical literature. Here, we present a thorough descriptive analysis of reports to a…”
    Get full text
    Journal Article
  2. 2

    Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016 by Su, John R., Moro, Pedro L., Ng, Carmen S., Lewis, Paige W., Said, Maria A., Cano, Maria V.

    Published in Journal of allergy and clinical immunology (01-04-2019)
    “…Anaphylaxis, a rare and potentially life-threatening hypersensitivity reaction, can occur after vaccination. We sought to describe reports of anaphylaxis after…”
    Get full text
    Journal Article
  3. 3

    Safety of the 9-Valent Human Papillomavirus Vaccine by Shimabukuro, Tom T, Su, John R, Marquez, Paige L, Mba-Jonas, Adamma, Arana, Jorge E, Cano, Maria V

    Published in Pediatrics (Evanston) (01-12-2019)
    “…The 9-valent human papillomavirus vaccine (9vHPV) was approved for females and males aged 9 to 26 years in 2014. We analyzed postlicensure surveillance reports…”
    Get full text
    Journal Article
  4. 4

    Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010–2017 by Hibbs, Beth F., Ng, Carmen S., Museru, Oidda, Moro, Pedro L., Marquez, Paige, Woo, Emily Jane, Cano, Maria V., Shimabukuro, Tom T.

    Published in Vaccine (29-01-2020)
    “…Vaccines administered into or too close to underlying joint structures have the potential to cause shoulder injuries. Limited data exist on the epidemiology of…”
    Get full text
    Journal Article
  5. 5

    Adverse events after vaccination among HIV-positive persons, 1990-2016 by Su, John R, Ng, Carmen, Lewis, Paige W, Cano, Maria V

    Published in PloS one (19-06-2018)
    “…Human immunodeficiency virus (HIV) causes immune dysregulation, potentially affecting response to vaccines in infected persons. We investigated if unexpected…”
    Get full text
    Journal Article
  6. 6

    Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017 by Su, John R., Haber, Penina, Ng, Carmen S., Marquez, Paige L., Dores, Graça M., Perez-Vilar, Silvia, Cano, Maria V.

    Published in Vaccine (11-02-2020)
    “…•VAERS received 1086 reports of EM/SJS/TEN during 1999–2017, mostly EM (984, 91%).•Most reports of SJS or TEN (52–100%), but few reports of EM (9%), were…”
    Get full text
    Journal Article
  7. 7

    Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011–July 2018 by McNeil, Michael M., Paradowska-Stankiewicz, Iwona, Miller, Elaine R., Marquez, Paige L., Seshadri, Srihari, Collins, Limone C., Cano, Maria V.

    Published in Vaccine (16-10-2019)
    “…In March 2011, the U.S. Food and Drug Administration licensed adenovirus type 4 and type 7 vaccine, live, oral (Barr Labs, Inc.) (adenovirus vaccine) for use…”
    Get full text
    Journal Article
  8. 8

    Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010–2015 by Myers, Tanya R, McNeil, Michael M, Ng, Carmen S, Li, Rongxia, Lewis, Paige W, Cano, Maria V

    Published in Vaccine (27-03-2017)
    “…Abstract Background Limited data are available describing the post-licensure safety of meningococcal vaccines, including Menveo®. We reviewed reports of…”
    Get full text
    Journal Article
  9. 9

    Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018 by Perez-Vilar, Silvia, Dores, Graça M., Marquez, Paige L., Ng, Carmen S., Cano, Maria V., Rastogi, Anuja, Lee, Lucia, Su, John R., Duffy, Jonathan

    Published in Vaccine (21-01-2022)
    “…Bexsero® (GlaxoSmithKline) is a four-component Neisseria meningitidis serogroup B vaccine (MenB-4C). It was licensed in the United States in 2015 for use among…”
    Get full text
    Journal Article
  10. 10

    Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005–2016 by Myers, Tanya R., McNeil, Michael M., Ng, Carmen S., Li, Rongxia, Marquez, Paige L., Moro, Pedro L., Omer, Saad B., Cano, Maria V.

    Published in Vaccine (11-09-2020)
    “…Post marketing safety evaluations of quadrivalent meningococcal diphtheria-toxoid conjugate vaccine (MenACWY-D) have focused on post-vaccination risk of…”
    Get full text
    Journal Article
  11. 11

    Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015 by Haber, Penina, Moro, Pedro L., Ng, Carmen, Lewis, Paige W., Hibbs, Beth, Schillie, Sarah F., Nelson, Noele P., Li, Rongxia, Stewart, Brock, Cano, Maria V.

    Published in Vaccine (25-01-2018)
    “…•Study included VAERS Hepatitis B reports from January 2005–December 2015.•Most reports (15,787, 78%), were following combination vaccines.•No new or…”
    Get full text
    Journal Article
  12. 12

    Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018 by Hesse, Elisabeth M., Shimabukuro, Tom T., Su, John R., Hibbs, Beth F., Dooling, Kathleen L., Goud, Ravi, Lewis, Paige, Ng, Carmen S., Cano, Maria V.

    “…Recombinant zoster vaccine (RZV; Shingrix), an adjuvanted glycoprotein vaccine, was licensed by the Food and Drug Administration (FDA) and recommended by the…”
    Get full text
    Journal Article Newsletter
  13. 13
  14. 14

    Administration Error Involving a Meningococcal Conjugate Vaccine — United States, March 1, 2010–September 22, 2015 by Su, John R., Miller, Elaine R., Duffy, Jonathan, Baer, Bethany M., Cano, Maria V.

    “…Su et al report on administration error involving Menveo, a conjugate vaccine that was recommended in October 2010 for routine use in adolescents to prevent…”
    Get full text
    Journal Article Newsletter
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Notes from the Field: Administration Error Involving a Meningococcal Conjugate Vaccine--United States, March 1, 2010-September 22, 2015 by Su, John R, Miller, Elaine R, Duffy, Jonathan, Baer, Bethany M, Cano, Maria V

    “…Menveo (GlaxoSmithKline, previously Novartis AG) is a conjugate vaccine that was recommended in October 2010 for routine use in adolescents (preferably aged 11…”
    Get full text
    Journal Article
  20. 20